Mathematics

Filters3 filters applied

Topic

Status

Corrected
No notice
From publisher notices and Retraction Watch. Not checked means nobody has looked yet.

Year

Readable here

Study type

41 papers1 Corrected Questions on this topic

2 filters appliedReadable here: Full text Year: 2020 and later Clear all

Sample size calculation for prevalence studies using Scalex and ScalaR calculators
Lin Naing, Rusli Bin Nordin, Hanif Abdul Rahman et al. · BMC Medical Research Methodology · 2022
Full textCC BY
Sample size determination: A practical guide for health researchers
Alaa Althubaiti · Journal of General and Family Medicine · 2022 · Review
Full textCC BY
Covasim: An agent-based model of COVID-19 dynamics and interventions
Cliff C. Kerr, Robyn M. Stuart, Dina Mistry et al. · PLOS Computational Biology · 2021
Full textCC BY
Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile
Gonzalo E. Mena, Pamela P. Martinez, Ayesha S. Mahmud et al. · Science · 2021
Full textCC BY
The coefficient of determination R-squared is more informative than SMAPE, MAE, MAPE, MSE and RMSE in regression analysis evaluation
Davide Chicco, Matthijs J. Warrens, Giuseppe Jurman · PeerJ Computer Science · 2021
Full textCC BY
Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols
Paul Z Chen, Niklas Bobrovitz, Zahra Premji et al. · eLife · 2021 · Meta-analysis
Full textCC BY
Determining sample size for progression criteria for pragmatic pilot RCTs: the hypothesis test strikes back!
M. Lewis, K. Bromley, C. J. Sutton et al. · Pilot and Feasibility Studies · 2021
Full textCC BY
Estimating worldwide effects of non-pharmaceutical interventions on COVID-19 incidence and population mobility patterns using a multiple-event study
Nikolaos Askitas, Konstantinos Tatsiramos, Bertrand Verheyden · Scientific Reports · 2021
Full textCC BY
Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis
Pratha Sah, Meagan C. Fitzpatrick, Charlotte F. Zimmer et al. · Proceedings of the National Academy of Sciences · 2021 · Meta-analysis
Full textCC BY
Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic
Meng-Jie Geng, Hai-Yang Zhang, Lin-Jie Yu et al. · Nature Communications · 2021
Full textCC BY
SARS-CoV-2 Transmission From People Without COVID-19 Symptoms
Michael A. Johansson, Talia M. Quandelacy, Sarah Kada et al. · JAMA Network Open · 2021
Full textCC BY
Black–White Risk Differentials in COVID-19 (SARS-COV2) Transmission, Mortality and Case Fatality in the United States: Translational Epidemiologic Perspective and Challenges
Laurens Holmes, Michael Enwere, Janille Williams et al. · International Journal of Environmental Research and Public Health · 2020
Full textCC BY
Use of directed acyclic graphs (DAGs) to identify confounders in applied health research: review and recommendations
Peter W G Tennant, Eleanor J Murray, Kellyn F Arnold et al. · International Journal of Epidemiology · 2020 · Review
Full textCC BY
Demographic science aids in understanding the spread and fatality rates of COVID-19
Jennifer Beam Dowd, Liliana Andriano, David M. Brazel et al. · Proceedings of the National Academy of Sciences · 2020
Full textCC BY
Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China
Péter Boldog, Tamás Tekeli, Zsolt Vizi et al. · Journal of Clinical Medicine · 2020
Full textCC BY
So you think you can PLS-DA?
Daniel Ruiz-Perez, Haibin Guan, Purnima Madhivanan et al. · BMC Bioinformatics · 2020
Full textCC BY
Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020
Tapiwa Ganyani, Cécile Kremer, Dongxuan Chen et al. · Eurosurveillance · 2020
Full textCC BY
Excess mortality during the COVID-19 outbreak in Italy: a two-stage interrupted time-series analysis
Matteo Scortichini, Rochelle Schneider dos Santos, Francesca De’ Donato et al. · International Journal of Epidemiology · 2020
Full textCC BY
Household Transmission of SARS-CoV-2
Zachary J. Madewell, Yang Yang, Ira M. Longini et al. · JAMA Network Open · 2020
Full textCC BY
Indications for healthcare surge capacity in European countries facing an exponential increase in coronavirus disease (COVID-19) cases, March 2020
Frederik Verelst, Elise Kuylen, Philippe Beutels · Eurosurveillance · 2020
Full textCC BY